The DOI matches its OpenAlex record; 4 of the 4 references it cites were found in a registry or an index.
Phenylketonuria: a review of current and future treatments.
Open accessAbstract
Phenylketonuria (PKU) is an autosomal recessive inborn error of metabolism caused by a deficiency in the hepatic enzyme phenylalanine hydroxylase (PAH). If left untreated, the main clinical feature is intellectual disability. Treatment, which includes a low Phe diet supplemented with amino acid formulas, commences soon after diagnosis within the first weeks of life. Although dietary treatment has been successful in preventing intellectual disability in early treated PKU patients, there are major issues with dietary compliance due to palatability of the diet. Other potential issues associated with dietary therapy include nutritional deficiencies especially vitamin D and B12. Suboptimal outcomes in cognitive and executive functioning have been reported in patients who adhere poorly to dietary therapy. There have been continuous attempts at improving the quality of medical foods including their palatability. Advances in dietary therapy such as the use of large neutral amino acids (LNAA) and glycomacropeptides (GMP; found within the whey fraction of bovine milk) have been explored. Gene therapy and enzyme replacement or substitution therapy have yielded more promising data in the recent years. In this review the current and possible future treatments for PKU are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Phase I Trial With Transgenic Bacteria Expressing Interleukin-10 in Crohn’s Disease
Braat, H., Rottiers, P., Hommes, D. W., Huyghebaert, N., Remaut, E., Remon, J., van Deventer, S. J. H., Neirynck, S., Peppelenbosch, M. P., & Steidler, L. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.03.028 · Cited by 786
Trefz, F. K., Burton, B. K., Longo, N., Casanova, M. M.-P., Gruskin, D. J., Dorenbaum, A., Kakkis, E. D., Crombez, E. A., Grange, D. K., Harmatz, P., et al. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2008.11.040 · Cited by 196
Phenylalanine ammonia-lyase. Induction and purification from yeast and clearance in mammals.
Fritz, R. R., Hodgins, D. S., & Abell, C. W. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33251-9 · Cited by 116
Evaluation of specific metabolic rates of major organs and tissues: Comparison between men and women
Wang, Z., Ying, Z., Bosy‐Westphal, A., Zhang, J., Heller, M., Later, W., Heymsfield, S. B., & Müller, M. J. (2011) · American Journal of Human Biology · doi:10.1002/ajhb.21137 · Cited by 70 · cited 1×
“This increase in metabolic activity is accompanied by an increase in liver mass (86), both of which are caused by the catabolism of excess Phe to phenylketones as well as energy lost from urinary excretion of Phe-derived organic acids (15).”
Background
Cited by
Half a century of amyloids: past, present and future
Ke, P. C., Zhou, R., Serpell, L. C., Riek, R., Knowles, T. P. J., Lashuel, H. A., Gazit, E., Hamley, I. W., Davis, T. P., Fändrich, M., et al. (2020) · Chemical Society Reviews · doi:10.1039/c9cs00199a · Cited by 568
Parthasarathy, A., Cross, P. J., Dobson, R. C. J., Adams, L. E., Savka, M. A., & Hudson, A. O. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2018.00029 · Cited by 358
Incomplete Penetrance and Variable Expressivity: From Clinical Studies to Population Cohorts
Kingdom, R., & Wright, C. F. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.920390 · Cited by 287
Aryl Transfer Strategies Mediated by Photoinduced Electron Transfer
Allen, A. R., Noten, E. A., & Stephenson, C. R. J. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00388 · Cited by 270
Metadata
- Authors
- Hafid, N. A., & Christodoulou, J.
- Venue
- PubMed
- Publisher
- National Institutes of Health
- Published
- 2015-10-01
- Volume
- 4
- Issue
- 4
- Pages
- 304-17
- OpenAlex
- W1915707355
- Cited by
- 185
- References
- 4
- FWCI
- 10.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Phenylketonuria: a review of current and future treatments. https://app.cochat.ai/papers/10.3978/j.issn.2224-4336.2015.10.07
- The paper
- Hafid, N. A., & Christodoulou, J. (2015). Phenylketonuria: a review of current and future treatments. PubMed. https://doi.org/10.3978/j.issn.2224-4336.2015.10.07
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.